For the year ending 2025-12-31.
| Income Statement | 2025-12-31 | |||
|---|---|---|---|---|
| Research and development | 45,619 | |||
| General and administrative | 20,745 | |||
| Total operating expenses | 66,364 | |||
| Loss from operations | -66,364 | |||
| Interest income | 6,603 | |||
| Interest expense | 2,469 | |||
| Loss on debt extinguishment | -681 | |||
| Other, net | 327 | |||
| Total other income, net | 3,126 | |||
| Net loss | -63,238 | |||
| Basic EPS | -2.19 | |||
| Diluted EPS | -2.19 | |||
| Basic Average Shares | 28,852,000 | |||
| Diluted Average Shares | 28,852,000 | |||
Alto Neuroscience, Inc. (ANRO)
Alto Neuroscience, Inc. (ANRO)